Photo de profil par défault

Anne Farina

Ingénieur(e)
Publications
Mar 2019 Cell reports

Nidogen-1 Contributes to the Interaction Network Involved in Pro-B Cell Retention in the Peri-sinusoidal Hematopoietic Stem Cell Niche.

Balzano M, De Grandis M, Vu Manh TP, Chasson L, Bardin F, Farina A, Sergé A, Bidaut G, Charbord P, Hérault L, Bailly AL, Cartier-Michaud A, Boned A, Dalod M, Duprez E, Genever P, Coles M, Bajenoff M, Xerri L, Aurrand-Lions M, Schiff C, Mancini SJC

May 2021 Oncoimmunology

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors.

Bertucci F, Boudin L, Finetti P, Van Berckelaer C, Van Dam P, Dirix L, ViensP, Gonçalves A, Ueno NT, Van Laere S, Birnbaum D, Mamessier E

May 2021 Genome medicine

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.

Bertucci F, Gonçalves A, Guille A, Adelaïde J, Garnier S, Carbuccia N, BillonE, Finetti P, Sfumato P, Monneur A, Pécheux C, Khran M, Brunelle S, Mescam L,Thomassin-Piana J, Poizat F, Charafe-Jauffret E, Turrini O, Lambaudie E,Provansal M, Extra JM, Madroszyk A, Gilabert M, Sabatier R, Vicier C, MamessierE, Chabannon C, Pakradouni J, Viens P, André F, Gravis G, Popovici C, BirnbaumD, Chaffanet M

May 2021 Nature communications

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas.

Amoozgar Z, Kloepper J, Ren J, Tay RE, Kazer SW, Kiner E, Krishnan S, PosadaJM, Ghosh M, Mamessier E, Wong C, Ferraro GB, Batista A, Wang N, Badeaux M,Roberge S, Xu L, Huang P, Shalek AK, Fukumura D, Kim HJ, Jain RK

May 2021 NPJ breast cancer

The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer.

Goncalves A, Finetti P, Birnbaum D, Bertucci F

Apr 2021 Nature communications

EFA6B regulates a stop signal for collective invasion in breast cancer.

Fayad R, Rojas MV, Partisani M, Finetti P, Dib S, Abelanet S, Virolle V, Farina A, Cabaud O, Lopez M, Birnbaum D, Bertucci F, Franco M, Luton F

Mar 2021 Nature Communications

Alternative lengthening of telomeres is notsynonymous with mutations in ATRX/DAXX.

de Nonneville A, Reddel RR

Feb 2021 Journal of Clinical Investigation

Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer.

Guo Y, Gabola M, Lattanzio R, Paul C, Pinet V, Tang R, Turali H, Bremond J, Longobardi C, Maurizy C, Da Costa Q, Finetti P, Boissière-Michot F, Rivière B, Lemmers C, Garnier S, Bertucci F, Zlobec I, Chebli K, Tazi J, Azar R, Blanchard JM, Sicinski P, Mamessier E, Lemmers B, Hahne M.

Feb 2021 Clinical Cancer Research

Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma.

Birnbaum DJ, Begg SKS, Finetti P, Vanderburg CR, Neyaz A, Kulkarni AS, Hank T, Tai EC, Deshpande V, Bertucci F, Birmbaum D, Lillemoe KD, Warshaw AL, Mino- Kenudson M, Fernandez-Del Castillo C, Ting DT, Liss AS

Jan 2021 Gut

Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma.

Aoki S, Inoue K, Klein S, Halvorsen S, Chen J, Matsui A, Nikmaneshi MR,Kitahara S, Hato T, Chen X, Kawakubo K, Nia HT, Chen I, Schanne DH, Mamessier E,Shigeta K, Kikuchi H, Ramjiawan RR, Schmidt TC, Iwasaki M, Yau T, Hong TS, QuaasA, Plum PS, Dima S, Popescu I, Bardeesy N, Munn LL, Borad MJ, Sassi S, Jain RK,Zhu AX, Duda DG

Nov 2020 Frontiers in Oncology

PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer.

Bertucci A, Bertucci F, Zemmour C, Lerebours F, Pierga JY, Levy C, Dalenc F, Grenier J, Petit T, Berline M, Gonçalves A

Mar 2020 NPJ Breast Cancer

The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype.

Bertucci F, Finetti P, Goncalves A, Birnbaum D

Aug 2019 Oncoimmunology

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma.

Billon E, Finetti P, Bertucci A, Niccoli P, Birnbaum D, Mamessier E, Bertucci F

Apr 2015 Nature

Tel1(ATM)-mediated interference suppresses clustered meiotic double-strand-break formation

Valerie Garcia*, Stephen Gray, Rachal M Allison, Tim J Cooper, Matthew J Neale* (*co-corresponding)

Methods in molecular biology (Clifton, N.J.)

Phage display and selections on purified antigens

Matz J, Chames P

Apr 2017 Annals of oncology : official journal of the European Society for Medical Oncology

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer.

M-Rabet M, Cabaud O, Josselin E, Finetti P, Castellano R, Farina A, Agavnian-Couquiaud E, Saviane G, Collette Y, Viens P, Gonçalves A, Ginestier C, Charafe-Jauffret E, Birnbaum D, Olive D, Bertucci F, Lopez M